Related Experiment Videos
HbA1c as an Independent Predictor of Peripheral Artery Disease: Nonlinear Threshold and Causal Evidence from NHANES
Xixi Guo1, Jianke Wang2, Qiang Guo3
1Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.
Insights
Elevated glycated hemoglobin (HbA1c) is independently and causally linked to peripheral artery disease (PAD) risk. This suggests HbA1c can help identify individuals at higher risk for PAD.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Epidemiology
Background:
- Peripheral artery disease (PAD) significantly contributes to cardiovascular disease burden, yet early detection biomarkers are limited.
- Glycated hemoglobin (HbA1c), a marker of long-term blood sugar control, has an incompletely understood association with PAD in the general population.
Purpose of the Study:
- To investigate the association between HbA1c levels and PAD in a large adult population.
- To explore the causal relationship between HbA1c and PAD risk using Mendelian randomization.
Main Methods:
- Analysis of 6284 adults from the National Health and Nutrition Examination Survey (NHANES) (1999-2004).
- PAD defined by ankle-brachial index ≤0.90; statistical models included logistic regression and restricted cubic splines.
- Two-sample Mendelian randomization (MR) using genome-wide association data for HbA1c and PAD.
Main Results:
- Each 1% increase in HbA1c correlated with increased PAD likelihood (fully adjusted OR 1.18).
- Highest HbA1c tertile showed over twofold PAD risk (OR 2.30) compared to the lowest.
- MR analysis confirmed a positive causal association between genetically predicted HbA1c and PAD risk (IVW OR 1.23, p=0.0002).
Conclusions:
- Elevated HbA1c is independently and causally associated with peripheral artery disease risk.
- A nonlinear dose-response pattern exists, with a steep rise in PAD risk below an HbA1c threshold of 6.11%.
- HbA1c shows potential as a biomarker for identifying individuals at elevated risk for PAD.
Abstract:
BackgroundPeripheral artery disease (PAD) is a major contributor to cardiovascular morbidity and mortality, yet reliable biomarkers for early detection remain limited. Glycated hemoglobin (HbA1c) reflects long-term glycemia, but its relationship with PAD in the general population remains incompletely understood.MethodsWe analyzed 6284 adults aged ≥40 years from the 1999-2004 National Health and Nutrition Examination Survey (NHANES). PAD was defined as an ankle-brachial index ≤0.90. Weighted logistic regression, restricted cubic spline, and threshold models evaluated associations between HbA1c and PAD. To further examine causality, a two-sample Mendelian randomization (MR) using genome-wide association data on HbA1c (n = 389,889) and PAD (7098 cases, 206541 controls) was conducted.ResultsIn NHANES, each 1% increment in HbA1c was linked to a higher likelihood of PAD (fully adjusted OR 1.18, 95% CI 1.04-1.34). Participants in the highest HbA1c tertile had more than a twofold greater risk compared with those in the lowest (OR 2.30, 95% CI 1.68-3.15). Restricted cubic spline analysis revealed a nonlinear relationship with a threshold at 6.11%, below which PAD risk rose steeply. In MR analysis, genetically predicted HbA1c was positively associated with PAD risk, showing that genetically predicted HbA1c was positively associated with PAD (IVW OR 1.23, 95% CI 1.10-1.37, p = 0.0002), with consistent results across sensitivity analyses.ConclusionElevated HbA1c is independently and causally linked to PAD risk, with a nonlinear dose-response pattern. These findings support HbA1c as a potential tool for identifying individuals at higher PAD risk.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Coronary Artery Disease I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Peripheral Artery Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Diabetes: Symptoms, Diagnosis, and Complications